Page last updated: 2024-11-07

methylprednisolone acetate and Spinal Diseases

methylprednisolone acetate has been researched along with Spinal Diseases in 11 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Spinal Diseases: Diseases involving the SPINE.

Research Excerpts

ExcerptRelevanceReference
"Clinical trials first began in 1960 with methylprednisolone acetate (Depo-Medrol) administered intrathecally, in an attempt to treat both disk disease and multiple sclerosis."4.77Dangers from methylprednisolone acetate therapy by intraspinal injection. ( Nelson, DA, 1988)
"Methylprednisolone acetate was injected into the L3-L4 disc, whereas methylprednisolone sodium succinate was injected into the L4-L5 disc."1.30Histologic changes in the intervertebral disc after intradiscal injections of methylprednisolone acetate in rabbits. ( Aoki, M; Iwata, H; Kato, F; Mimatsu, K, 1997)
"Spinal epidural lipomatosis has been reported frequently in association with chronic systemic corticosteroid therapy, but thus far only one case has been attributed to local epidural corticosteroid injections."1.30Symptomatic spinal epidural lipomatosis after local epidural corticosteroid injections: case report. ( Lavyne, MH; Sandberg, DI, 1999)
"A case is reported in which chemical meningism occurred after lumbar facet joint block with methylprednisolone acetate and bupivacaine."1.28Chemical meningism after lumbar facet joint block with local anaesthetic and steroids. ( Collett, BJ; Lomax, DM; Thomson, SJ, 1991)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19902 (18.18)18.7374
1990's4 (36.36)18.2507
2000's3 (27.27)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scuderi, GJ1
Cuellar, JM1
Cuellar, VG1
Yeomans, DC1
Carragee, EJ1
Angst, MS1
Shoham, S1
Marr, KA1
Khot, A1
Bowditch, M1
Powell, J1
Sharp, D1
Amin, N1
Brancaccio, R1
Cohen, D1
Carrera, GF1
Williams, AL1
Aoki, M1
Kato, F1
Mimatsu, K1
Iwata, H1
Sandberg, DI1
Lavyne, MH1
Rothbart, P1
Thomson, SJ1
Lomax, DM1
Collett, BJ1
Nelson, DA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Using Inflammatory Biomarkers and EMG Results to Predict Epidural Injection Response in Patients Diagnosed With Lumbar Stenosis[NCT03511053]11 participants (Actual)Interventional2017-12-19Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Pain Disability Questionnaire

Measures how pain is affecting the patients lifestyle on a scale from 0 to 10 as defined by each question. The questionnaire contains 15 questions that each range on a scale form 0 to 10. The total score of the questionnaire ranges from 0 to 150. Lower values represent a better outcome. (NCT03511053)
Timeframe: Change between baseline, 1 month and 2 months post injection

Interventionscore on a scale (Mean)
Average at baselineAverage at 1 monthAverage at 2 monthsAverage at 1 month changeAverage at 2 month change
All Participants77.553.364.327.316.2

Swiss Spinal Stenosis Questionnaire

Measures how pain due to spinal stenosis is effected the patient based on quality of life/pain questions and satisfaction questions for months 1 and 2 (no scales are used) SSSQ scores are reported in percentages 0-100%, higher scores indicate worse outcomes. (NCT03511053)
Timeframe: Change between baseline, 1 month and 2 months post injection

InterventionPercentage (Mean)
Average at baselineAverage at 1 monthAverage at 2 monthsAverage at 1 month changeAverage at 2 month change
All Participants64.153.253.511.710.3

Visual Analogue Scale

Number rating of back/leg pain from 0 to 10, 0 being no pain/discomfort, 10 being extreme pain/discomfort (NCT03511053)
Timeframe: Change between baseline, 1 month and 2 months post injection

Interventionscore on a scale (Mean)
Average at baselineAverage at 1 monthAverage at 2 monthsAverage 1 month changeAverage 2 month change
All Participants6.25.05.00.81

Reviews

2 reviews available for methylprednisolone acetate and Spinal Diseases

ArticleYear
Current concepts in evaluation of the lumbar facet joints.
    Critical reviews in diagnostic imaging, 1984, Volume: 21, Issue:2

    Topics: Arthrography; Back Pain; Cartilage, Articular; Diagnosis, Differential; Humans; Joint Diseases; Lumb

1984
Dangers from methylprednisolone acetate therapy by intraspinal injection.
    Archives of neurology, 1988, Volume: 45, Issue:7

    Topics: Demyelinating Diseases; Humans; Injections, Epidural; Injections, Spinal; Intervertebral Disc; Methy

1988

Trials

1 trial available for methylprednisolone acetate and Spinal Diseases

ArticleYear
The use of intradiscal steroid therapy for lumbar spinal discogenic pain: a randomized controlled trial.
    Spine, 2004, Apr-15, Volume: 29, Issue:8

    Topics: Chronic Disease; Disability Evaluation; Female; Humans; Injections, Intralesional; Intervertebral Di

2004

Other Studies

8 other studies available for methylprednisolone acetate and Spinal Diseases

ArticleYear
Spinal and paraspinal infections associated with contaminated methylprednisolone acetate injections - Michigan, 2012-2013.
    MMWR. Morbidity and mortality weekly report, 2013, May-17, Volume: 62, Issue:19

    Topics: Aged; Anti-Inflammatory Agents; Disease Outbreaks; Drug Contamination; Female; Humans; Injections, E

2013
Epidural interferon gamma-immunoreactivity: a biomarker for lumbar nerve root irritation.
    Spine, 2009, Oct-01, Volume: 34, Issue:21

    Topics: Adult; Aged; Biomarkers; Bupivacaine; Cohort Studies; Epidural Space; Female; Follow-Up Studies; Hum

2009
Treatment of iatrogenic fungal infections: a black mold defines a new gray zone in medicine.
    Annals of internal medicine, 2013, Feb-05, Volume: 158, Issue:3

    Topics: Anti-Inflammatory Agents; Antifungal Agents; Arthritis; Centers for Disease Control and Prevention,

2013
Cutaneous reactions to injectable corticosteroids.
    Dermatitis : contact, atopic, occupational, drug, 2006, Volume: 17, Issue:3

    Topics: Aged; Anti-Inflammatory Agents; Bupivacaine; Diagnosis, Differential; Drug Eruptions; Female; Humans

2006
Histologic changes in the intervertebral disc after intradiscal injections of methylprednisolone acetate in rabbits.
    Spine, 1997, Jan-15, Volume: 22, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Calcinosis; Injections, Spinal; Intervertebral Disc; Lumbar Verte

1997
Symptomatic spinal epidural lipomatosis after local epidural corticosteroid injections: case report.
    Neurosurgery, 1999, Volume: 45, Issue:1

    Topics: Aged; Anti-Inflammatory Agents; Decompression, Surgical; Humans; Injections, Epidural; Laminectomy;

1999
Unilateral headache with features of hemicrania continua and cervicogenic headache--a case report.
    Headache, 1992, Volume: 32, Issue:9

    Topics: Adult; Anti-Inflammatory Agents; Female; Headache; Humans; Injections, Spinal; Lidocaine; Methylpred

1992
Chemical meningism after lumbar facet joint block with local anaesthetic and steroids.
    Anaesthesia, 1991, Volume: 46, Issue:7

    Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Dura Mater; Female; Humans; Lumbar Vertebrae; Meni

1991